Vilin Bio Med quarterly results and financials

Vilin Bio Med (VILINBIO)₹54.550.00%(8 Nov 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (standalone), Vilin Bio Med reported sales of ₹32.51 Cr, up 215.6% from Mar 2025, and net profit of ₹1.77 Cr, up 1,866.7% year on year. For the year to Mar 2026, sales were ₹42.15 Cr and net profit ₹1.92 Cr.

Sales (Mar 2026): ₹32.51 Cr
Net profit (Mar 2026): ₹1.77 Cr
Sales (FY Mar 2026): ₹42.15 Cr
Net profit (FY Mar 2026): ₹1.92 Cr
EPS (Mar 2026): ₹1.16
Borrowings (Mar 2026): ₹0.20 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Vilin Bio Med quarterly results

₹ crore unless stated; each column is a quarter.

Vilin Bio Med Quarterly results
	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	8.19	7.63	8.14	4.48	10.30	9.64	32.51
Expenses	6.75	6.27	8.74	4.08	9.97	9.33	29.78
Operating Profit	1.48	1.40	−0.58	0.43	0.38	0.35	2.87
OPM %	18.0%	18.3%	−7.0%	9.4%	3.6%	3.5%	8.8%
Other Income	0.01	0.10	0.21	0.21	0.24	0.00	0.00
Interest	0.34	0.39	0.42	0.42	0.45	0.08	0.00
Depreciation	0.07	0.07	0.04	0.06	0.02	0.06	0.20
Profit before tax	1.09	1.05	−0.82	0.17	0.16	0.21	2.66
Tax %	35.2%	26.0%	−25.9%	18.8%	33.4%	25.0%	32.9%
Net Profit	0.68	0.76	−0.60	0.11	0.09	0.14	1.77
EPS (Rs)	0.68	0.54	−0.43	0.08	0.06	0.10	1.16

Vilin Bio Med profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Vilin Bio Med Profit and loss
	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	16.58	11.51	11.18	12.29	15.75	14.78	42.15
Expenses	15.73	10.70	10.45	9.74	14.98	14.04	39.11
Operating Profit	0.92	0.87	0.78	2.59	0.84	0.80	3.21
OPM %	5.5%	7.5%	6.9%	21.0%	5.3%	5.4%	7.6%
Other Income	0.00	0.00	0.00	0.01	0.31	0.46	0.00
Interest	0.42	0.45	0.52	0.66	0.80	0.86	0.08
Depreciation	0.30	0.25	0.21	0.16	0.12	0.09	0.27
Profit before tax	0.21	0.17	0.05	1.79	0.24	0.32	2.86
Tax %	20.0%	25.0%	25.1%	30.4%	26.1%	25.9%	32.0%
Net Profit	0.15	0.11	0.02	1.24	0.15	0.21	1.92
EPS (Rs)	0.47	0.35	0.08	1.25	0.10	0.15	1.26
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Vilin Bio Med balance sheet

₹ crore, at each year end.

Vilin Bio Med Balance sheet
	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3.29	3.29	3.29	9.91	13.89	13.91	15.21
Reserves	3.94	4.05	4.10	0.73	8.87	9.10	13.12
Borrowings	4.52	5.50	5.28	4.91	6.80	2.56	0.20
Other Liabilities	2.22	1.00	0.85	2.07	2.72	2.08	6.33
Total Liabilities	13.97	13.84	13.52	17.62	32.28	27.65	34.86
Fixed Assets	2.12	1.86	1.64	1.50	1.37	1.27	2.86
CWIP	0.00	0.00	0.00	0.00	0.00	1.58	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	11.85	11.98	11.88	16.12	30.91	24.80	32.00
Inventories	2.10	2.05	2.27	0.87	4.45	4.39	7.20
Trade receivables	7.28	7.66	7.80	5.61	5.69	6.32	15.98
Cash & equivalents	0.06	0.04	0.03	0.02	6.03	0.05	1.46
Total Assets	13.97	13.84	13.52	17.62	32.28	27.65	34.86

Vilin Bio Med cash flow

₹ crore, for each year.

Vilin Bio Med Cash flow
	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−1.45	−0.99	0.20	−1.65	−7.40	0.21	0.69
Cash from investing activity	−0.01	0.00	0.00	−0.02	0.31	−1.10	−0.29
Cash from financing activity	1.50	0.97	−0.21	1.69	8.86	−5.09	1.00
Net cash flow	0.02	−0.01	0.00	0.00	1.76	−5.97	1.40
Capex	0.03	0.00	0.00	0.04	0.00	1.58	0.31
Free cash flow	−1.49	−1.01	0.22	−1.70	−7.44	−1.36	0.41
CFO / OP %	−156.0%	−112.0%	29.0%	−43.0%	−888.0%	37.0%	49.0%

Vilin Bio Med ratios

Working-capital days and returns, by year.

Vilin Bio Med Ratios
	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	160	242	254	166	131	156	138
Inventory days	56	83	94	45	125	120	70
Days payable	49	33	26	60	55	38	32
Cash conversion cycle	166	292	321	150	202	237	175
Working capital days	111	204	212	45	76	195	168
ROCE %	—	4.9%	4.3%	17.2%	4.6%	4.2%	10.8%

Vilin Bio Med: frequently asked questions

What are the latest quarterly results of Vilin Bio Med?

For the Mar 2026 quarter, Vilin Bio Med reported sales of ₹32.51 Cr, up 215.6% year on year and net profit of ₹1.77 Cr, up 1,866.7% year on year. The operating margin was 8.8%.

What is the annual revenue of Vilin Bio Med?

Vilin Bio Med's sales for the year to Mar 2026 were ₹42.15 Cr.

What is the net profit of Vilin Bio Med?

Net profit for the year to Mar 2026 was ₹1.92 Cr. Earnings per share over the same trailing period were ₹1.26.

How much debt does Vilin Bio Med have?

Vilin Bio Med reported borrowings of ₹0.20 Cr at Mar 2026, against cash and equivalents of ₹1.46 Cr.

What is the free cash flow of Vilin Bio Med?

Cash from operations was ₹0.69 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.41 Cr.

Loading…